Format

Send to

Choose Destination
J Med Food. 2017 Jan;20(1):79-85. doi: 10.1089/jmf.2016.0070. Epub 2016 Dec 23.

Effects of Alpha-Lipoic Acid Supplementation on Plasma Adiponectin Levels and Some Metabolic Risk Factors in Patients with Schizophrenia.

Author information

1
1 Department of Bromatology, Faculty of Pharmacy, University of Belgrade , Belgrade, Serbia .
2
2 Faculty of Medicine, University of Belgrade , Belgrade, Serbia .
3
3 Clinic for Psychiatry, Clinical Centre of Serbia , Belgrade, Serbia .
4
4 Department of Medical Biochemistry, Faculty of Pharmacy, University of Belgrade , Belgrade, Serbia .
5
5 Centre of Research Excellence in Nutrition and Metabolism, Institute for Medical Research, University of Belgrade , Belgrade, Serbia .

Abstract

Adiponectin is an adipocyte-derived plasma protein with insulin-sensitizing and anti-inflammatory properties and is suggested to be a biomarker of metabolic disturbances. The aim of this study was to investigate the effects of alpha-lipoic acid (ALA) on plasma adiponectin and some metabolic risk factors in patients with schizophrenia. The plasma adipokine levels (adiponectin and leptin), routine biochemical and anthropometric parameters, markers of oxidative stress, and the serum phospholipid fatty acid profile in eighteen schizophrenic patients at baseline, in the middle, and at the end of a 3-month long supplementation period with ALA (500 mg daily) were determined. A significant increase in the plasma adiponectin concentrations, as well as a decrease in fasting glucose and aspartate aminotransferase activity (AST), was found. Baseline AST activity was independently correlated with the adiponectin concentrations. Our data show that ALA can improve plasma adiponectin levels and may play a potential role in the treatment of metabolic risk factor in patients with schizophrenia. Future randomized controlled trials are needed to confirm these preliminary investigations.

KEYWORDS:

adipocytokines; antipsychotic drugs; metabolic disturbances; nutraceuticals

PMID:
28009525
DOI:
10.1089/jmf.2016.0070
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center